- Top Workplaces
- Verastem Oncology
Verastem Oncology
Verastem Oncology (Nasdaq: VSTM) is a development-stage biopharmaceutical company committed to the development and commercialization of new
medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling
pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition.
medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling
pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and focal adhesion kinase (FAK) inhibition.
Purpose
To create a world where no cancer patient ever runs out of options.
Vision
To accelerate the development of a complimentary portfolio of targeted cancer therapies.
Mission
To establish VS-6766 as the backbone therapy for RAS-driven tumors.
Additional Culture Details
Turn potential into possible
We believe that seeing potential isn’t nearly enough. Potential is an equation that must be solved, a story that must be written, and a mountain that must
be climbed – not only for some but for all. That’s why we must act to connect all areas of potential to improve survival today, no matter wh... Read more
We believe that seeing potential isn’t nearly enough. Potential is an equation that must be solved, a story that must be written, and a mountain that must
be climbed – not only for some but for all. That’s why we must act to connect all areas of potential to improve survival today, no matter wh... Read more
Values
- Purposeful
- We are purposeful, acting deliberately to positively impact patients and others. This is our focus—because this is what’s most important.
Recent Awards
2022
Company Snapshots
